Advertisement

Topics

Christie Medical Christie to display VeinViewer at 2018 AAD Meeting

05:00 EST 15 Feb 2018 | PR Web

Christie Medical Holdings, the leader in near-infrared vein finding technology, will be displaying VeinViewer® at the 2018 American Academy of Dermatology Annual Meeting

MEMPHIS, Tenn. (PRWEB) February 15, 2018

Christie® Medical Holdings, the leader in near-infrared vein finding technology, will be displaying VeinViewer® at the 2018 American Academy of Dermatology Annual Meeting from February 16-20 at the San Diego Convention Center in California in booth No. 4930. Attendees will learn how they can take their practice to the next level with VeinViewer, the only high definition vein visualization technology. Conference participants are invited to in-booth demonstrations of the VeinViewer Vision2 and VeinViewer Flex to see how they can improve targeting for cosmetic procedures and potentially reduce complications.

VeinViewer uses near infrared (NIR) light to detect superficial veins by projecting the vein pattern directly onto the skin in real-time. Clinicians are easily able to identify and avoid vessels, including veins that are commonly clustered around the eyes, when performing cosmetic injections. VeinViewer can see peripheral veins up to 10mm deep and blood patterns up to 15mm deep, making VeinViewer ideal for assisting with injectable procedures. Additionally, VeinViewer has been shown to help with target mapping for vein treatment procedures, such as sclerotherapy, through identification of the deeper feeder vein for effective treatment of spider telangiectasia.

“Attendees to AAD will see how VeinViewer can improve the patient experience and comfort,” says George Pinho, president, Christie Medical Holdings. “By easily identifying vessels, VeinViewer can help circumvent potential complications and help promote better patient outcomes.”

To learn more about Christie vein finding devices: VeinViewer Vision2 and VeinViewer Flex please visit http://www.christiemed.com.

About Christie Medical Holdings, Inc.

Christie Medical Holdings Inc. is a global company based in Memphis, Tenn., that discovers, develops and commercializes medical technologies. The company’s market-leading product, VeinViewer, is manufactured in the USA. It is a mobile vascular imaging system that allows health care providers to clearly see accessible vasculature as a real time HD image, directly on the surface of the skin. Christie Medical Holdings Inc. is owned by Christie Digital Systems Inc., a global visual technologies company and a subsidiary of Ushio Inc., Japan (JP:6925). For more information on Christie Digital Systems or Christie Medical Holdings, visit http://www.christiemed.com.

For cautions associated to Christie Medical Holdings products, please visit http://www.christiemed.com/cautions

For the original version on PRWeb visit: http://www.prweb.com/releases/2018/02/prweb15205669.htm

NEXT ARTICLE

More From BioPortfolio on "Christie Medical Christie to display VeinViewer at 2018 AAD Meeting"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Dermatology
Acne Dermatology Eczema Psoriasis Wound Care Dermatology is the medical specialty concerned with the diagnosis and treatment of skin disorders (Oxford Medical Dictionary). As well as studying how the skin works, dermatology covers...

Wound management
Anything that breaks the skin is a wound because when the skin is broken, there's a risk of germs getting into the body and causing an infection. Follow and track Wound Care News on BioPortfolio: Wound Car...